Event Details
ANZBMS Webinar: Denosumab discontinuation: from the bedside to the bench and back again
Date:
22 Sep 2025 at 6:00 PM to 7:00 PM
Host:
Australian & New Zealand Bone Mineral Society (ANZBMS)
Denosumab has revolutionised the management of osteoporosis with continued bone gains and fracture prevention with ongoing use. However, stopping therapy leads to rebound bone loss and increased risk of the very fractures that denosumab treatment aimed to prevent.
This presentation will outline the clinical problem of the rebound phenomenon following denosumab discontinuation, how preclinical studies inform our understanding of potential mechanisms, and how we can address this clinical challenge.
Presented by Dr Albert Kim, Staff Specialist, Westmead Hospital
Register